Related Experiment Video
Updated: Apr 15, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
HPV vaccine: Current status and future directions.
Sushil Kumar1, Manash Biswas2, Tony Jose3
1Director and Commandant, Armed Forces Medical College, Pune 411040, India.
The Human Papillomavirus (HPV) vaccine effectively prevents cervical pre-cancers and other HPV-related cancers. Ongoing research focuses on developing improved, broader-spectrum, and therapeutic vaccines for comprehensive HPV control.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Human Papillomavirus (HPV) infection is a primary cause of cervical cancer.
- Current HPV vaccines are prophylactic, L1 VLP-based, species-specific, thermolabile, and costly.
- Controversies surround HPV vaccine efficacy, safety, vaccination age, and use in males and HPV-infected individuals.
Purpose of the Study:
- To review the efficacy and limitations of current HPV vaccines.
- To discuss the development and necessity of novel prophylactic and therapeutic HPV vaccines.
- To highlight ongoing research for comprehensive control of HPV-related malignancies.
Main Methods:
- Literature review of HPV vaccine efficacy and development.
- Analysis of mathematical modeling for cervical cancer prevention.
- Discussion of ongoing research in vaccine technology.
Main Results:
- HPV vaccines are proven effective in preventing Cervical Intraepithelial Neoplasia (CIN).
- Mathematical modeling suggests reasonable certainty of HPV vaccine effectiveness in preventing cervical cancer.
- Vaccines also prevent other anogenital and oropharyngeal malignancies.
Conclusions:
- Current HPV vaccines offer significant protection against HPV-related diseases.
- Development of cheaper, thermostable, broad-spectrum, and therapeutic vaccines is crucial.
- Future research aims for complete control of HPV-related cancers.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production
Vaccinations
Human Virome
Vaccines
Microorganisms in Medicine and Therapeutics